Comment on Publications from OpT2mise Study

Diabetes Technol Ther. 2016 Jul;18(7):446-7. doi: 10.1089/dia.2016.0064. Epub 2016 Apr 4.
No abstract available

Publication types

  • Letter

MeSH terms

  • Diabetes Mellitus, Type 1 / diagnosis
  • Diabetes Mellitus, Type 1 / drug therapy*
  • Diabetes Mellitus, Type 2 / diagnosis
  • Diabetes Mellitus, Type 2 / drug therapy*
  • Diabetes Mellitus, Type 2 / epidemiology
  • Diabetes Mellitus, Type 2 / ethnology
  • Diagnostic Errors*
  • Drug Monitoring / ethics
  • Drug Monitoring / standards
  • Humans
  • Hypoglycemic Agents / administration & dosage*
  • Hypoglycemic Agents / adverse effects
  • Hypoglycemic Agents / therapeutic use
  • Injections, Subcutaneous / instrumentation
  • Insulin / administration & dosage*
  • Insulin / adverse effects
  • Insulin / therapeutic use
  • Insulin Infusion Systems / adverse effects
  • Patient Selection / ethics
  • Practice Guidelines as Topic*
  • Randomized Controlled Trials as Topic* / ethics
  • Randomized Controlled Trials as Topic* / standards
  • Republic of North Macedonia / epidemiology
  • Risk
  • Socioeconomic Factors

Substances

  • Hypoglycemic Agents
  • Insulin